FDA Has Linked More Than 100 Deaths to Ozempic, Wegovy and Similar Drugs: Report
Death reports linked to Ozempic and similar drugs indicate users suffered from intestinal masses, stomach paralysis, pancreatic cancer and seizures.
Death reports linked to Ozempic and similar drugs indicate users suffered from intestinal masses, stomach paralysis, pancreatic cancer and seizures.
Eli Lilly failed to warn users that side effects of Trulicity may cause gastroparesis, despite numerous studies, case reports and medical literature indicating that users may experience severe stomach paralysis.
Health experts urge women not to use Ozempic or similar drugs to increase fertility, due to increased risks of birth defects and miscarriage.
Drug maker plans to pursue legal remedies against compounding pharmacies, medical spas and other entities that claim to sell generic versions of Mounjaro and Zepbound.
New York woman indicates she had to undergo an emergency resection of her bowels and now needs to use a colostomy bag as a result of gastroparesis and intestinal obstructions from Mounjaro
Researchers noted that side effects of Ozempic and similar drugs were particularly linked to an increased risk in eating disorders, such as self-induced vomiting and fear of eating.
The New Jersey production facility has a history or quality control problems over the last several years, according to FDA records.
Novo Nordisk faces lawsuits over inadequate warnings about stomach paralysis caused by Ozempic and Wegovy, which outline how the GLP-1 semaglutide may permanently alter the stomach’s natural digestive function.
The agency notes it has not completely ruled out the suicide risk, and it is continuing to investigate the potential side effects of Ozempic, Wegovy, Mounjaro and similar diabetes or weight loss drugs.
Dozens of lawsuits have been filed by users of Ozempic, Wegovy and other GLP-1 drugs involving stomach paralsysis or gastroparesis. However, Eli Lilly maintains that Mounjaro lawsuits should be excluded from the MDL.